Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Safety Trial of Allogeneic Mesenchymal Stem Cells for Systemic Lupus Erythematosus

NCT03171194 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.

NCT NCT03171194
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03171194 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Safety Trial of Allogeneic Mesenchymal Stem Cells for Systemic Lupus Erythematosus
Lead sponsor
Medical University of South Carolina
Phase
Phase 1
Overall status
Completed
Start date
April 27, 2017
Completion date
October 25, 2018
Enrollment
6 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

system; lupus erythematosus